Submission Details
| 510(k) Number | K203517 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 30, 2020 |
| Decision Date | April 16, 2021 |
| Days to Decision | 137 days |
| Submission Type | Traditional |
| Review Panel | Radiology (RA) |
| Summary | Summary PDF |
K203517 is an FDA 510(k) clearance for the Saige-Q, a Radiological Computer-assisted Prioritization Software For Lesions (Class II — Special Controls, product code QFM), submitted by DeepHealth, Inc. (Cambridge, US). The FDA issued a Cleared decision on April 16, 2021, 137 days after receiving the submission on November 30, 2020. This device falls under the Radiology review panel. Regulated under 21 CFR 892.2080.
| 510(k) Number | K203517 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 30, 2020 |
| Decision Date | April 16, 2021 |
| Days to Decision | 137 days |
| Submission Type | Traditional |
| Review Panel | Radiology (RA) |
| Summary | Summary PDF |
| Product Code | QFM — Radiological Computer-assisted Prioritization Software For Lesions |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 892.2080 |
| Definition | Radiological Computer-assisted Prioritization Software For Lesions Is An Image Processing Device Intended To Aid In Prioritization And Triage Of Time Sensitive Patient Detection And Diagnosis Based On The Analysis Of Medical Images Acquired From Radiological Signal Acquisition Systems. The Device Identifies Or Prioritizes Time Sensitive Imaging For Review By Prespecified Clinical Users Based On Software-based Image Analysis But Does Not Provide Information From The Image Analysis Other Than Triage And Notification. |